Home>products>Virus>Zika virus>Zika virus Envelope / Zika-E
Text Size:AAA
Browse by ZIKV Product Category
ZIKV Viral Molecule
ZIKV Strain Source
ZIKV Infection Receptor

    ZIKV Infection Associated
    ZIKV Information

    Browse by Virus Product Category
    Browse by Virus Product Category

    Zika virus  Envelope / Zika-E

    Zika virus  Envelope / Zika-E Protein & Antibody

    ZIKV-E ProteinZIKV-E AntibodyZIKV-E cDNACloneZIKV-E 

    Zika virus Envelope / Zika-E Background

    Envelope of Zika virus is resposible for receptor binding and membrane. Analysis of the envelope protein of Zika, from Brazilian Zika SPH2015 (KU321639), indicates predicted B and T cell epitopes in peptides that are consistent to those reported for dengue, YFYF and Japanese encephalitis.

    The envelope Domain II B cell epitope, to which much dengue non-neutralizing cross reaction is attributed, is also conserved also in Zika virus, consistent with prior field observations of cross reactivity with dengue and YF. Domain III of the Zika envelope protein, likely the main specific neutralizing domain, is distinct from recent Brazilian dengue isolates and a recent Peruvian YF isolate (GQ379163), 76% of possible major histocompatibility complex class (MHC) I and MHC II binding peptides and potential B cell linear epitopes are unique to Zika virus.

    Zika virus Envelope / Zika-E Related Studies

    1. Marina Basarab specialty registrar. et al .Zika virus. BMJ 2016; 352:i1049 doi: 10.1136/bmj.i1049
    2. Pinto Júnior VL, et al. Zika virus: a review to clinicians, Acta Med Port 2015 Nov-Dec;28(6):760-765
    3. L Zammarchi, et al.Zika virus infection in a traveler returning to Europe from Brazil, March 2015
    4. Arturo Galindo-Fraga, et al. Zika virus: A new epidemic on our doorstep. Rev Inves Clin.2015, 67: 329-32
    Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"